FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q104058129> ?p ?o ?g. }

• Q104058129 description "2020 nî lūn-bûn" @default.
• Q104058129 description "2020 ވަނަ އަހަރުގެ ޑިސެމްބަރުމަހުގެ 3ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ސައިންޓިފިކް ލިޔުމެއް" @default.
• Q104058129 description "2020年の論文" @default.
• Q104058129 description "2020年学术文章" @default.
• Q104058129 description "2020年学术文章" @default.
• Q104058129 description "2020年学术文章" @default.
• Q104058129 description "2020年学术文章" @default.
• Q104058129 description "2020年学术文章" @default.
• Q104058129 description "2020年学术文章" @default.
• Q104058129 description "2020年學術文章" @default.
• Q104058129 description "2020年學術文章" @default.
• Q104058129 description "2020年學術文章" @default.
• Q104058129 description "2020年學術文章" @default.
• Q104058129 description "2020年學術文章" @default.
• Q104058129 description "2020년 논문" @default.
• Q104058129 description "article científic" @default.
• Q104058129 description "article scientific" @default.
• Q104058129 description "article scientifique" @default.
• Q104058129 description "articol științific" @default.
• Q104058129 description "articolo scientifico" @default.
• Q104058129 description "artigo científico" @default.
• Q104058129 description "artigo científico" @default.
• Q104058129 description "artigo científico" @default.
• Q104058129 description "artikel ilmiah" @default.
• Q104058129 description "artikull shkencor" @default.
• Q104058129 description "artikulong pang-agham" @default.
• Q104058129 description "artykuł naukowy" @default.
• Q104058129 description "artículo científico publicado en 2020" @default.
• Q104058129 description "artículu científicu" @default.
• Q104058129 description "bilimsel makale" @default.
• Q104058129 description "bài báo khoa học" @default.
• Q104058129 description "naučni članak" @default.
• Q104058129 description "scienca artikolo" @default.
• Q104058129 description "scientific article published on 03 December 2020" @default.
• Q104058129 description "scientific article published on 3 December 2020" @default.
• Q104058129 description "scientific article published on 3 December 2020" @default.
• Q104058129 description "teaduslik artikkel" @default.
• Q104058129 description "tieteellinen artikkeli" @default.
• Q104058129 description "tudományos cikk" @default.
• Q104058129 description "vedecký článok" @default.
• Q104058129 description "vetenskaplig artikel" @default.
• Q104058129 description "videnskabelig artikel udgivet 3. december 2020" @default.
• Q104058129 description "vitenskapelig artikkel" @default.
• Q104058129 description "vitskapeleg artikkel" @default.
• Q104058129 description "vědecký článek" @default.
• Q104058129 description "wetenschappelijk artikel" @default.
• Q104058129 description "wissenschaftlicher Artikel" @default.
• Q104058129 description "επιστημονικό άρθρο" @default.
• Q104058129 description "мақолаи илмӣ" @default.
• Q104058129 description "наукова стаття, опублікована в грудні 2020" @default.
• Q104058129 description "научна статия" @default.
• Q104058129 description "научная статья" @default.
• Q104058129 description "научни чланак" @default.
• Q104058129 description "научни чланак" @default.
• Q104058129 description "מאמר מדעי" @default.
• Q104058129 description "مقالة علمية نشرت في 3 ديسمبر 2020" @default.
• Q104058129 description "৩ ডিসেম্বর ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q104058129 description "บทความทางวิทยาศาสตร์" @default.
• Q104058129 description "სამეცნიერო სტატია" @default.
• Q104058129 name "500 mg as bolus followed by an extended infusion of 1500 mg of meropenem every 8 h failed to achieve in one-third of the patients an optimal PK/PD against non-resistant strains of these organisms: is CRRT responsible for this situation?" @default.
• Q104058129 name "500 mg as bolus followed by an extended infusion of 1500 mg of meropenem every 8 h failed to achieve in one-third of the patients an optimal PK/PD against non-resistant strains of these organisms: is CRRT responsible for this situation?" @default.
• Q104058129 name "500 mg as bolus followed by an extended infusion of 1500 mg of meropenem every 8 h failed to achieve in one-third of the patients an optimal PK/PD against non-resistant strains of these organisms: is CRRT responsible for this situation?" @default.
• Q104058129 type Item @default.
• Q104058129 label "500 mg as bolus followed by an extended infusion of 1500 mg of meropenem every 8 h failed to achieve in one-third of the patients an optimal PK/PD against non-resistant strains of these organisms: is CRRT responsible for this situation?" @default.
• Q104058129 label "500 mg as bolus followed by an extended infusion of 1500 mg of meropenem every 8 h failed to achieve in one-third of the patients an optimal PK/PD against non-resistant strains of these organisms: is CRRT responsible for this situation?" @default.
• Q104058129 label "500 mg as bolus followed by an extended infusion of 1500 mg of meropenem every 8 h failed to achieve in one-third of the patients an optimal PK/PD against non-resistant strains of these organisms: is CRRT responsible for this situation?" @default.
• Q104058129 prefLabel "500 mg as bolus followed by an extended infusion of 1500 mg of meropenem every 8 h failed to achieve in one-third of the patients an optimal PK/PD against non-resistant strains of these organisms: is CRRT responsible for this situation?" @default.
• Q104058129 prefLabel "500 mg as bolus followed by an extended infusion of 1500 mg of meropenem every 8 h failed to achieve in one-third of the patients an optimal PK/PD against non-resistant strains of these organisms: is CRRT responsible for this situation?" @default.
• Q104058129 prefLabel "500 mg as bolus followed by an extended infusion of 1500 mg of meropenem every 8 h failed to achieve in one-third of the patients an optimal PK/PD against non-resistant strains of these organisms: is CRRT responsible for this situation?" @default.
• Q104058129 P1433 Q104058129-8306A81F-55D1-4CCF-9804-0515017CC1DA @default.
• Q104058129 P1476 Q104058129-E236FEBC-CACA-4892-A54D-4935E12360C4 @default.
• Q104058129 P2093 Q104058129-13AA17F9-199F-4532-AB28-3A00AA7B82BC @default.
• Q104058129 P2093 Q104058129-810318F2-73A0-429C-90DD-3B5AAD9FA3A3 @default.
• Q104058129 P2093 Q104058129-93F672C8-3653-4FDB-A43B-D47B392B67C3 @default.
• Q104058129 P2093 Q104058129-A6397C0C-E82F-4575-A46F-425911757800 @default.
• Q104058129 P2093 Q104058129-A9C060B1-B8CE-4BCA-9958-84E9EF54E13A @default.
• Q104058129 P2093 Q104058129-B4842CE2-FC9F-43A9-8E25-E143F2BC39FD @default.
• Q104058129 P2093 Q104058129-E7B35832-8003-46F7-AB12-F01308616384 @default.
• Q104058129 P304 Q104058129-B6C72794-B195-4927-BC8E-104CD4468561 @default.
• Q104058129 P31 Q104058129-BAB9F00E-1772-46DD-81C9-47003E36A5A1 @default.
• Q104058129 P356 Q104058129-C0ED6A1F-2C8E-469C-A12A-C40A70318339 @default.
• Q104058129 P433 Q104058129-882E1A36-097F-43FC-A555-69FA5389F8BC @default.
• Q104058129 P478 Q104058129-FB24B025-9919-48C8-8464-2E1F7E1D2E83 @default.
• Q104058129 P577 Q104058129-0FF5EFFA-F1E5-4590-B386-0FA05D35A465 @default.
• Q104058129 P698 Q104058129-BA4A9D6C-92C1-4599-BBDB-5FEA25ECF73D @default.
• Q104058129 P921 Q104058129-58966AAB-27EC-4DAD-9E26-AEEE42397686 @default.
• Q104058129 P932 Q104058129-E7902ED9-78DC-47EB-8800-6A9AD292ABF6 @default.
• Q104058129 P356 S13613-020-00777-2 @default.
• Q104058129 P698 33270168 @default.
• Q104058129 P1433 Q18712109 @default.
• Q104058129 P1476 "500 mg as bolus followed by an extended infusion of 1500 mg of meropenem every 8 h failed to achieve in one-third of the patients an optimal PK/PD against non-resistant strains of these organisms: is CRRT responsible for this situation?" @default.
• Q104058129 P2093 "Andrea Gallerani" @default.
• Q104058129 P2093 "David De Bels" @default.
• Q104058129 P2093 "Leonel Barret Gutierrez" @default.
• Q104058129 P2093 "Luc Kugener" @default.
• Q104058129 P2093 "Patrick M Honore" @default.
• Q104058129 P2093 "Rachid Attou" @default.
• Q104058129 P2093 "Sebastien Redant" @default.
• Q104058129 P304 "163" @default.
• Q104058129 P31 Q13442814 @default.

• next